Omeros Corp. Files 8-K Report
Ticker: OMER · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1285819
| Field | Detail |
|---|---|
| Company | Omeros Corp (OMER) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, sec-filing
Related Tickers: OMER
TL;DR
OMER filed an 8-K, mostly financial docs. Nothing major to see here.
AI Summary
On December 19, 2024, Omeros Corp. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no other specific events detailed in the provided text. The company is incorporated in Washington and headquartered in Seattle.
Why It Matters
This filing indicates routine corporate reporting, providing updates on financial statements and exhibits for Omeros Corp.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for financial statements and exhibits, not indicating any immediate material changes or risks.
Key Numbers
- 001-34475 — SEC File Number (Identifies the company's filing with the SEC.)
- 91-1663741 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- OMEROS CORP (company) — Registrant
- 201 Elliott Avenue West (location) — Principal Executive Offices
- Seattle (location) — City of Principal Executive Offices
- WA (location) — State of Principal Executive Offices
- 98119 (location) — Zip Code of Principal Executive Offices
- 206-676-5000 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 19, 2024.
What is Omeros Corp.'s principal executive office address?
Omeros Corp.'s principal executive office is located at 201 Elliott Avenue West, Seattle, WA 98119.
What is the company's SEC file number?
The company's SEC file number is 001-34475.
What is the SIC code for Omeros Corp.?
The Standard Industrial Classification (SIC) code for Omeros Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 462 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-12-19 09:20:15
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share OMER The Nasdaq
Filing Documents
- omer20241210_8k.htm (8-K) — 24KB
- ex_755914.htm (EX-99.1) — 22KB
- ex_755914img001.jpg (GRAPHIC) — 3KB
- 0001437749-24-037898.txt ( ) — 187KB
- omer-20241219.xsd (EX-101.SCH) — 3KB
- omer-20241219_def.xml (EX-101.DEF) — 11KB
- omer-20241219_lab.xml (EX-101.LAB) — 15KB
- omer-20241219_pre.xml (EX-101.PRE) — 11KB
- omer20241210_8k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On December 19, 2024, Omeros Corporation issued a press release announcing the results of a primary statistical analysis for narsoplimab, the company's first-in-class monoclonal antibody targeting MASP-2, the effector enzyme of the lectin pathway of complement, in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release, dated December 19, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OMEROS CORPORATION Date: December 19, 2024 By: /s/ Gregory A. Demopulos Gregory A. Demopulos, M.D. President, Chief Executive Officer and Chairman of the Board of Directors